Zogenix’s Fintepla Reduces Drop Seizure Rates, But Is It Enough?

Red dart arrow hitting in the target center of dartboard with modern city and sunset background. Target business, achieve and victory concept .
Fintepla reduced monthly drop seizures in Lennox-Gastaut syndrome

More from Clinical Trials

More from R&D